Two Sigma Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,300
| Closed | -$314K | – | 2578 |
|
|
2024
Q1 | $314K | Sell |
4,300
-1,100
| -20% | -$80.4K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $386K | Sell |
5,400
-1,200
| -18% | -$85.7K | ﹤0.01% | 2021 |
|
|
2023
Q3 | $395K | Sell |
6,600
-1,000
| -13% | -$59.9K | ﹤0.01% | 1876 |
|
|
2023
Q2 | $548K | Sell |
7,600
-800
| -10% | -$57.7K | ﹤0.01% | 1777 |
|
|
2023
Q1 | $618K | Sell |
8,400
-3,100
| -27% | -$228K | ﹤0.01% | 1856 |
|
|
2022
Q4 | $768K | Buy |
11,500
+7,332
| +176% | +$490K | ﹤0.01% | 1697 |
|
|
2022
Q3 | $224K | Sell |
4,168
-160
| -4% | -$8.6K | ﹤0.01% | 2161 |
|
|
2022
Q2 | $241K | Buy |
4,328
+801
| +23% | +$44.6K | ﹤0.01% | 2204 |
|
|
2022
Q1 | $247K | Buy |
3,527
+481
| +16% | +$33.7K | ﹤0.01% | 2312 |
|
|
2021
Q4 | $293K | Buy |
+3,046
| New | +$293K | ﹤0.01% | 2149 |
|
|
2021
Q2 | – | Sell |
-36,664
| Closed | -$3.49M | – | 2577 |
|
|
2021
Q1 | $3.49M | Sell |
36,664
-56,586
| -61% | -$5.38M | 0.01% | 1009 |
|
|
2020
Q4 | $5.79M | Sell |
93,250
-182,421
| -66% | -$11.3M | 0.02% | 764 |
|
|
2020
Q3 | $16.4M | Sell |
275,671
-37,190
| -12% | -$2.21M | 0.05% | 370 |
|
|
2020
Q2 | $21.8M | Buy |
312,861
+5,290
| +2% | +$369K | 0.06% | 304 |
|
|
2020
Q1 | $14M | Sell |
307,571
-94,897
| -24% | -$4.31M | 0.05% | 380 |
|
|
2019
Q4 | $26.2M | Sell |
402,468
-21,962
| -5% | -$1.43M | 0.06% | 320 |
|
|
2019
Q3 | $26.4M | Sell |
424,430
-86,722
| -17% | -$5.39M | 0.06% | 320 |
|
|
2019
Q2 | $36.4M | Sell |
511,152
-15,389
| -3% | -$1.1M | 0.09% | 266 |
|
|
2019
Q1 | $41.3M | Buy |
526,541
+248,145
| +89% | +$19.5M | 0.1% | 242 |
|
|
2018
Q4 | $23.6M | Buy |
278,396
+33,156
| +14% | +$2.81M | 0.06% | 343 |
|
|
2018
Q3 | $42M | Sell |
245,240
-55,464
| -18% | -$9.5M | 0.1% | 234 |
|
|
2018
Q2 | $38.9M | Buy |
300,704
+57,067
| +23% | +$7.38M | 0.1% | 242 |
|
|
2018
Q1 | $25.1M | Buy |
243,637
+221,695
| +1,010% | +$22.8M | 0.07% | 352 |
|
|
2017
Q4 | $1.87M | Buy |
21,942
+14,427
| +192% | +$1.23M | 0.01% | 1278 |
|
|
2017
Q3 | $638K | Buy |
7,515
+4,809
| +178% | +$408K | ﹤0.01% | 1662 |
|
|
2017
Q2 | $205K | Buy |
+2,706
| New | +$205K | ﹤0.01% | 2112 |
|
|
2016
Q1 | – | Sell |
-3,514
| Closed | -$238K | – | 2086 |
|
|
2015
Q4 | $238K | Sell |
3,514
-1,122
| -24% | -$76K | ﹤0.01% | 1595 |
|
|
2015
Q3 | $248K | Buy |
4,636
+160
| +4% | +$8.56K | ﹤0.01% | 1569 |
|
|
2015
Q2 | $282K | Sell |
4,476
-41,197
| -90% | -$2.6M | ﹤0.01% | 1638 |
|
|
2015
Q1 | $2.2M | Buy |
45,673
+1,924
| +4% | +$92.6K | 0.02% | 728 |
|
|
2014
Q4 | $1.45M | Buy |
43,749
+8,977
| +26% | +$298K | 0.01% | 897 |
|
|
2014
Q3 | $1.02M | Buy |
34,772
+8,015
| +30% | +$235K | 0.01% | 919 |
|
|
2014
Q2 | $1.04M | Buy |
26,757
+17,793
| +198% | +$692K | 0.01% | 983 |
|
|
2014
Q1 | $377K | Buy |
+8,964
| New | +$377K | ﹤0.01% | 1327 |
|
|
2013
Q3 | – | Sell |
-15,055
| Closed | -$352K | – | 1722 |
|
|
2013
Q2 | $352K | Buy |
+15,055
| New | +$352K | 0.01% | 1163 |
|